Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Published loading...Updated

New Alzheimer’s drug disappoints in trials

Summary by Ground News
Gantenerumab is part of a class of injected drugs designed to remove sticky protein pieces called beta amyloid from the brain. A buildup of those pieces is a hallmark of Alzheimer's. Roche, the company behind the drug, said it appeared to remove less of the protein pieces than expected.

8 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

KCRG broke the news in Cedar Rapids, United States on Wednesday, November 16, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal